84 related articles for article (PubMed ID: 10582682)
1. Point mutations and deletions of the Bcl10 gene in solid tumors and malignant lymphomas.
Lee SH; Shin MS; Kim HS; Park WS; Kim SY; Lee HK; Park JY; Oh RR; Jang JJ; Park KM; Han JY; Kang CS; Lee JY; Yoo NJ
Cancer Res; 1999 Nov; 59(22):5674-7. PubMed ID: 10582682
[TBL] [Abstract][Full Text] [Related]
2. BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridization.
Achuthan R; Bell SM; Carr IM; Leek JP; Roberts P; Horgan K; Markham AF; Selby PJ; MacLennan KA
J Pathol; 2002 Jan; 196(1):59-66. PubMed ID: 11748643
[TBL] [Abstract][Full Text] [Related]
3. Detection of point mutations of BCL10 gene in hepatocellular carcinoma tissues: report of 46 cases.
Jihua C; Xisheng L; Shengli C; Zongxian C; Guang C; Ruyu D
Hum Mutat; 2000 May; 15(5):482-3. PubMed ID: 10790217
[TBL] [Abstract][Full Text] [Related]
4. Lack of Bcl10 gene mutations in laryngeal squamous cell carcinoma.
Ronchetti D; Intini D; Pruneri G; Neri A; Pignataro L
J Laryngol Otol; 2002 Aug; 116(8):610-2. PubMed ID: 12389689
[TBL] [Abstract][Full Text] [Related]
5. Lack of Bcl10 mutations in malignant cartilaginous tumors.
Park YK; Park HR; Kim YW; Chi SG; Unni KK
Int J Mol Med; 2002 Mar; 9(3):217-9. PubMed ID: 11836626
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors.
Mathew S; Murty VV; Bosl GJ; Chaganti RS
Cancer Res; 1994 Dec; 54(23):6265-9. PubMed ID: 7954476
[TBL] [Abstract][Full Text] [Related]
7. Mutations in Bcl10 are very rare in colorectal cancer.
Stone JG; Rowan AJ; Tomlinson IP; Houlston RS
Br J Cancer; 1999 Jul; 80(10):1569-70. PubMed ID: 10408399
[TBL] [Abstract][Full Text] [Related]
8. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.
Ohshima K; Muta H; Kawasaki C; Muta K; Deyev V; Kanda M; Kumano Y; Podack ER; Kikuchi M
Int J Oncol; 2001 Aug; 19(2):283-9. PubMed ID: 11445840
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of the BCL10 gene in childhood solid malignancies.
Miao J; Kusafuka T; Udatsu Y; Okada A
Med Pediatr Oncol; 2002 Dec; 39(6):543-6. PubMed ID: 12376974
[TBL] [Abstract][Full Text] [Related]
11. Imbalances of chromosome arm 1p in pediatric and adult germ cell tumors are caused by true allelic loss: a combined comparative genomic hybridization and microsatellite analysis.
Zahn S; Sievers S; Alemazkour K; Orb S; Harms D; Schulz WA; Calaminus G; Göbel U; Schneider DT
Genes Chromosomes Cancer; 2006 Nov; 45(11):995-1006. PubMed ID: 16897744
[TBL] [Abstract][Full Text] [Related]
12. BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma.
Bullinger L; Leupolt E; Schaffner C; Mertens D; Bentz M; Lichter P; Döhner H; Stilgenbauer S
Leukemia; 2000 Aug; 14(8):1490-2. PubMed ID: 10942247
[TBL] [Abstract][Full Text] [Related]
13. Infrequent somatic Fas mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT-type lymphoma.
Grønbaek K; Ralfkiaer E; Kalla J; Skovgaard GL; Guldberg P
J Pathol; 2003 Sep; 201(1):134-40. PubMed ID: 12950026
[TBL] [Abstract][Full Text] [Related]
14. BCL10 is not a major target for frequent loss of 1p in testicular germ cell tumors.
Kakinuma H; Habuchi T; Ito T; Mishina M; Sato K; Satoh S; Akao T; Ogawa O; Kato T
Cancer Genet Cytogenet; 2001 Apr; 126(2):134-8. PubMed ID: 11376806
[TBL] [Abstract][Full Text] [Related]
15. BCL10 single nucleotide polymorphism and its association with CSF dissemination of primary intracranial germ cell tumors.
Hayashi Y; Watanabe T; Nakada M; Kita D; Hayashi Y; Uchiyama N; Hamada J
Pediatr Neurosurg; 2009; 45(4):291-5. PubMed ID: 19690445
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the arginine-rich protein gene, in lung, breast, and prostate cancers, and in squamous cell carcinoma of the head and neck.
Shridhar R; Shridhar V; Rivard S; Siegfried JM; Pietraszkiewicz H; Ensley J; Pauley R; Grignon D; Sakr W; Miller OJ; Smith DI
Cancer Res; 1996 Dec; 56(24):5576-8. PubMed ID: 8971156
[TBL] [Abstract][Full Text] [Related]
17. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
18. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
Xu X; An Q; Zhang J; Tang P; Cheng S
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
[TBL] [Abstract][Full Text] [Related]
19. Lack of Bcl10 mutations in testicular germ cell tumours and derived cell lines.
van Schothorst EM; Mohkamsing S; van Gurp RJ; Oosterhuis JW; van der Saag PT; Looijenga LH
Br J Cancer; 1999 Jul; 80(10):1571-4. PubMed ID: 10408400
[TBL] [Abstract][Full Text] [Related]
20. Absence of post-transcriptional RNA modifications of BCL10 in human malignant mesothelioma and colorectal cancer.
Apostolou S; Murthy SS; Kolachana P; Jhanwar SC; Testa JR
Genes Chromosomes Cancer; 2001 Jan; 30(1):96-8. PubMed ID: 11107182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
